Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 1
1988 1
1989 1
1990 1
1991 2
1992 3
1993 2
1994 4
1996 2
1997 1
1998 4
1999 4
2000 4
2001 6
2002 4
2003 9
2004 7
2005 1
2006 6
2007 7
2008 3
2009 3
2010 3
2011 1
2012 5
2013 5
2014 2
2015 1
2018 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma.
Opat S, Tedeschi A, Linton K, McKay P, Hu B, Chan H, Jin J, Sobieraj-Teague M, Zinzani PL, Coleman M, Thieblemont C, Browett P, Ke X, Sun M, Marcus R, Portell CA, Ardeshna K, Bijou F, Walker P, Hawkes EA, Mapp S, Ho SJ, Talaulikar D, Zhou KS, Co M, Li X, Zhou W, Cappellini M, Tankersley C, Huang J, Trotman J. Opat S, et al. Among authors: tankersley c. Clin Cancer Res. 2021 Dec 1;27(23):6323-6332. doi: 10.1158/1078-0432.CCR-21-1704. Epub 2021 Sep 15. Clin Cancer Res. 2021. PMID: 34526366 Free PMC article.
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study.
Opat S, Tedeschi A, Hu B, Linton KM, McKay P, Leitch S, Coleman M, Zinzani PL, Jin J, Sun M, Sobieraj-Teague M, Browett P, Ke X, Thieblemont C, Ardeshna K, Bijou F, Walker P, Hawkes EA, Ho SJ, Zhou K, Liang Z, Xu J, Tankersley C, Delarue R, Co M, Trotman J. Opat S, et al. Among authors: tankersley c. Blood Adv. 2023 Nov 28;7(22):6801-6811. doi: 10.1182/bloodadvances.2023010668. Blood Adv. 2023. PMID: 37682792 Free PMC article. Clinical Trial.
Leptin prevents respiratory depression in obesity.
O'donnell CP, Schaub CD, Haines AS, Berkowitz DE, Tankersley CG, Schwartz AR, Smith PL. O'donnell CP, et al. Among authors: tankersley cg. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1477-84. doi: 10.1164/ajrccm.159.5.9809025. Am J Respir Crit Care Med. 1999. PMID: 10228114
Leptin, obesity, and respiratory function.
O'Donnell CP, Tankersley CG, Polotsky VP, Schwartz AR, Smith PL. O'Donnell CP, et al. Among authors: tankersley cg. Respir Physiol. 2000 Feb;119(2-3):163-70. doi: 10.1016/s0034-5687(99)00111-5. Respir Physiol. 2000. PMID: 10722859 Review.
Interpreting Penh in mice.
Mitzner W, Tankersley C. Mitzner W, et al. Among authors: tankersley c. J Appl Physiol (1985). 2003 Feb;94(2):828-31; author reply 831-2. doi: 10.1152/japplphysiol.00815.2002. J Appl Physiol (1985). 2003. PMID: 12531918 Free article. No abstract available.
90 results